Irving, Texas-based McKesson Corporation (MCK) provides healthcare services in the U.S. and internationally. With a market cap of $65.7 billion, McKesson operates through the U.S. Pharmaceutical ...

Stockouts of HIV testing kits and limited access to testing facilities further hinder accurate data collection in communities. In addition, the majority of people living with HIV do not have access to ...

The goal in treating ulcerative colitis is to reduce the inflammation, hopefully leading to remission. The two leading treatment options are medication and surgery. Approximately 70 percent of ...

No treatment option is perfectly effective for everyone, Dr. Yu said, but since medications were first developed for the condition decades ago, “we’ve come a long way.” Katie Mogg is a ...

A leaked Liverpool home kit for the 2025/26 season suggests it will be darker red than recent designs. Nike's contract with the Reds ends this season and Adidas is reputedly taking over as the ...

Agencies across the country that received federal money to address neglected sexual assault kits need to do a better job of following up on test results, including supporting survivors and ...

The latest trading session saw McKesson (MCK) ending at $513.67, denoting a +0.86% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.76%.

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on ...